Cost-Effectiveness Analysis of Lamivudine for the Treatment of Chronic Hepatitis B
- 1 May 2000
- journal article
- clinical trial
- Published by Springer Nature in PharmacoEconomics
- Vol. 17 (5) , 409-427
Abstract
No abstract availableKeywords
This publication has 57 references indexed in Scilit:
- Immunisation against hepatitis B in Taiwan.Gut, 1996
- A Preliminary Trial of Lamivudine for Chronic Hepatitis B InfectionNew England Journal of Medicine, 1995
- Occurrence of hepatocellular carcinoma and decompensation in western european patients with cirrhosis type BHepatology, 1995
- Long-term effect of interferon therapy in chronic hepatitis BJournal of Hepatology, 1994
- Survival and prognostic factors in 366 patients with compensated cirrhosis type B: a multicenter studyJournal of Hepatology, 1994
- Cost-utility analysis.BMJ, 1993
- Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literatureJournal of Hepatology, 1993
- Hepatitis B-related sequelae. Prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriersArchives of internal medicine (1960), 1990
- Mechanisms of Action of InterferonsSeminars in Liver Disease, 1989
- Natural course after the development of cirrhosis in patients with chronic type B hepatitis: a prospective studyLiver International, 1989